+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bladder Cancer Treatment Drugs Markets in China

  • PDF Icon

    Report

  • 235 Pages
  • June 2023
  • Region: China
  • AMID Co
  • ID: 1081212

China's demand for Bladder Cancer Treatment Drugs will continue to grow at about 12% by 2032

China's demand for Bladder Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2012, 2017 and 2022) and long-term forecasts through 2027 and 2032 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

Table of Contents

I. INTRODUCTION
  • Report Scope and Methodology
  • Executive Summary
II. BUSINESS ENVIRONMENT
  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties
III. BLADDER CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS
  • Bladder Cancer Treatment Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Bladder Cancer Treatment Drugs Sales Volume
  • Major Producer Facility Locations
  • Major Producers’ Sales Volume and Market Share
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investment
  • Technology Development
IV. BLADDER CANCER TREATMENT DRUGS PRODUCTION AND DEMAND
  • Bladder Cancer Overview
  • Bladder Cancer Treatment Drugs Market Overview
  • Bladder Cancer Treatment Drugs Market Overview by Classification
  • Intraluminal Perfusion Agentsnilateral Chemotherapy Drug
  • First-line Chemotherapy Drug
  • Immunomodulator
  • Other Drugs
  • Bladder Cancer Treatment Drugs Import and Export by Classification
  • Bladder Cancer Treatment Drugs Import
  • Import of Unilateral Chemotherapy Drug
  • Import of First-Line Chemotherapy Drug
  • Import of Intraluminal Perfusion Agents
  • Import of Immunomodulator
  • Import of Other Drugs
  • Bladder Cancer Treatment Drugs Export
  • Export of Unilateral Chemotherapy Drug
  • Export of First-Line Chemotherapy Drug
  • Export of Intraluminal Perfusion Agents
  • Export of Immunomodulator
  • Export of Other Drugs
  • Market Overview by Drug’s Active Principle
  • Market Overview by Producers
  • Pricing Trend
V. BLADDER CANCER TREATMENT DRUGS MARKET OUTLOOK
  • Bladder Cancer Treatment Drugs Markets Outlook Overview
  • Government Regulation
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits
VI. MARKETING STRATEGIES
  • Distribution System in China
  • China's Distribution System
  • Bladder Cancer Treatment Drugs Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China’s Market Entry
  • Licensing
  • Franchising
  • E-commerce
  • Trading Companies and Local Agents
  • Representative Offices and Chinese Subsidiaries
  • Wholly Foreign Owned Enterprise
VII. BLADDER CANCER TREATMENT DRUGS PRODUCER DIRECTORY
  • Profiles of Bladder Cancer Treatment Drugs Producers
LIST OF TABLES
I. INTRODUCTION
  • Economic Outlook Summary
II. BUSINESS ENVIRONMENT
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade
III. BLADDER CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS
  • Top 14 Bladder Cancer Treatment Drugs Sales Volume and Market Share
  • Bladder Cancer Treatment Drugs Sales Volume
  • Major Producer Facility Location
  • Major Bladder Cancer Treatment Drugs Producer Sales Volume and Their Market Share
  • Major Foreign Investment in China
IV. BLADDER CANCER TREATMENT DRUGS PRODUCTION AND DEMAND
  • Bladder Cancer Treatment Drugs Import by Country
  • Bladder Cancer Treatment Drugs Export by Country
  • Bladder Cancer Treatment Drugs Sales Volume by Drugs Classification
  • Bladder Cancer Treatment Drugs Import by Drugs Classification
  • Bladder Cancer Treatment Drugs Export by Drugs Classification
  • Top 14 Bladder Cancer Treatment Drugs Medication Value and Their Market Share
  • Top 14 Bladder Cancer Treatment Drugs Sales Volume and Their Market Share
  • Bladder Cancer Treatment Drugs Major Producer, Sales Volume, and Market Share
V. BLADDER CANCER TREATMENT DRUGS MARKET OUTLOOK
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits
LIST OF CHARTS
I. INTRODUCTION
  • Bladder Cancer Treatment Drugs Sales Volume
II. BUSINESS ENVIRONMENT
  • China’s GDP and Growth Rate
  • Industrial Output by Ownership
  • China’s Imports and Exports
III. BLADDER CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS
  • Bladder Cancer Treatment Drugs Sales Volume
  • Bladder Cancer Treatment Drugs Sales Volume by Drugs Classification
  • Top 14 Bladder Cancer Treatment Drugs Market Share
IV. BLADDER CANCER TREATMENT DRUGS PRODUCTION AND DEMAND
  • Bladder Cancer Treatment Drugs Sales Volume
  • Bladder Cancer Treatment Drugs Import
  • Bladder Cancer Treatment Drugs Import by Country
  • Bladder Cancer Treatment Drugs Export
  • Bladder Cancer Treatment Drugs Export by Country
  • Bladder Cancer Treatment Drugs Sales Volume by Classification
  • Intraluminal Perfusion Agents Sales Volume and Market Sharenilateral Chemotherapy Drug Sales Volume and Market Share
  • First-Line Chemotherapy Drug Sales Volume and Market Share
  • Immunomodulator Sales Volume and Market Share
  • Other Drugs Sales Volume and Market Share
  • Bladder Cancer Treatment Drugs Import by Classificationnilateral Chemotherapy Drug Import and Market Share
  • First-Line Chemotherapy Drug Import and Market Share
  • Intraluminal Perfusion Agents Import and Market Share
  • Immunomodulator Import and Market Share
  • Other Drugs Import and Market Share
  • Bladder Cancer Treatment Drugs Export by Drugs Classificationnilateral Chemotherapy Drug Export and Market Share
  • First-Line Chemotherapy Drug Export and Market Share
  • Intraluminal Perfusion Agents Export and Market Share
  • Immunomodulator Export and Market Share
VI. MARKETING STRATEGIES
  • China’s Distribution Channel

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Schering-Plough China Inc.
  • Bristol-Myers Squibb China Inc